Steven M. Pitzenberger

2.0k citations

49 papers · 1.5k indexed · h-index 20

Immunology and Allergy top 5%
Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 3
Organic Chemistry top 5%
- Synthesis and Biological Evaluation 5
Pharmaceutical Science top 5%
Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism 3
Infectious Diseases
- HIV/AIDS drug development and treatment 5
Molecular Biology
- Chemical Synthesis and Analysis 5
- Protein Structure and Dynamics 4
Cancer Research
- Cancer, Lipids, and Metabolism 4
Spectroscopy
- Analytical Chemistry and Chromatography 3
Surgery
- Lipoproteins and Cardiovascular Health 3

Co-authors: Keith M. Witherup Paul Anderson Harri G. Ramjit Sándor Varga Michael J. Salvatore Amy C. Graham William C. Lumma Richard W. Ransom
Cited by: Immunology and Allergy Pharmacology Organic Chemistry
Journals: Proceedings of the National Academy of Sciences (1 paper)Journal of the American Chemical Society (3 papers)Biochemistry (3 papers)
Partner nations: United States Germany Canada

In The Last Decade

Steven M. Pitzenberger

47 papers receiving 1.4k citations

Peers

Countries citing papers authored by Steven M. Pitzenberger

Since Specialization

Citations

This map shows the geographic impact of Steven M. Pitzenberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Pitzenberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Pitzenberger more than expected).

Fields of papers citing papers by Steven M. Pitzenberger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven M. Pitzenberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Pitzenberger. The network helps show where Steven M. Pitzenberger may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Steven M. Pitzenberger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven M. Pitzenberger Line = papers co-authored together Steven M. Pitzenberger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Mechanism of the Solution Oxidation of Rofecoxib Under Alkaline Conditions Pharmaceutical Research ·Paul A. Harmon,Stephen E. Biffar,Steven M. Pitzenberger,Robert A. Reed	2005	8
2	A novel oxidative degradation pathway of indomethacin under the stressing by hydrogen peroxide Tetrahedron Letters ·Min Li,Beth A. Conrad,Russell G. Maus,Steven M. Pitzenberger,Raju Subramanian,Xueguang Fang,Jeffery A. Kinzer,Holly J. Perpall	2005	10
3	Identification and quantitation of extractables from cellulose acetate butyrate (CAB) and estimation of their in vivo exposure levels Journal of Pharmaceutical and Biomedical Analysis ·Decheng Ma,Walter Wasylaschuk,Christopher A. Beasley,Zhongxi Zhao,Paul A. Harmon,John M. Ballard,Steven M. Pitzenberger,Sándor Varga,Robert A. Reed	2004	4
4	BIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMR Drug Metabolism and Disposition ·Raju Subramanian,Charles C. Lin,Jonathan Z. Ho,Steven M. Pitzenberger,Maria Victoria Silva Elipe,Christopher R. Gibson,Matthew P. Braun,Xiao Yu,James L. Yergey,Rominder Singh	2003	9
5	Conformation of a novel tetrapeptide inhibitor NH₂‐d‐Trp‐d‐Met‐Phe(pCl)‐Gla‐NH₂bound to farnesyl‐protein transferase Journal of Peptide Research ·Michael J. Bogusky,Steven M. Pitzenberger,V M Garsky,Joseph Culberson,Kenneth S. Koblan,Andrew Wallace,Antonello Pessi	1999	7
6	Characterization of a Solid State Reaction Product from a Lyophilized Formulation of a Cyclic Heptapeptide. A Novel Example of an Excipient-Induced Oxidation Pharmaceutical Research ·David C. Dubost,Michael J. Kaufman,Jeffrey A. Zimmerman,Michael J. Bogusky,Arthur B. Coddington,Steven M. Pitzenberger	1996	28
7	Martinelline and Martinellic Acid, Novel G-Protein Linked Receptor Antagonists from the Tropical Plant Martinella iquitosensis (Bignoniaceae) Journal of the American Chemical Society ·Keith M. Witherup,Richard W. Ransom,Amy C. Graham,Aurora M. Bernard,Michael J. Salvatore,William C. Lumma,Paul Anderson,Steven M. Pitzenberger,Sándor Varga	1995	253
8	Species differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and human. Drug Metabolism and Disposition ·Thomayant Prueksaritanont,Suresh K. Balani,L M Dwyer,Joan D. Ellis,L R Kauffman,S Varga,Steven M. Pitzenberger,Anthony D. Theoharides	1995	12
9	Solution structure of the cytoplasmic domain of phospholamban: phosphorylation leads to a local perturbation in secondary structure Biochemistry ·Russell J. Mortishire‐Smith,Steven M. Pitzenberger,Carl J. Burke,C. Russell Middaugh,Victor M. Garsky,Robert G. Johnson	1995	63
10	Transglutaminase Inhibition by 2-[(2-Oxopropyl)thio]imidazolium Derivatives: Mechanism of Factor XIIIa Inactivation Biochemistry ·Kurt Freund,K Doshi,Stanley L. Gaul,David A. Claremon,David C. Remy,John J. Baldwin,Steven M. Pitzenberger,Andrew M. Stern	1994	91
11	Structure of synthetic peptide analogues of an eggshell protein of Schistosoma mansoni Protein Science ·C. Russell Middaugh,James A. Ryan,Carl J. Burke,Henryk Mach,Adel M. Naylor,Michael J. Bogusky,Steven M. Pitzenberger,Hanlee P. Ji,John S. Cordingley,John A. Thomson	1993	3
12	In vivo and in vitro metabolism studies on a class III antiarrhythmic agent. Drug Metabolism and Disposition ·S. Vickers,C A Duncan,P H Kari,Carl F. Homnick,J.M. Elliott,Steven M. Pitzenberger,M Hichens,Kamlesh P. Vyas	1993	9
13	The solution conformation Ac‐Pen‐Arg‐Gly‐Asp‐Cys‐OH, a potent fibrinogen receptor antagonist Biopolymers ·Michael J. Bogusky,Adel M. Naylor,Michael Mertzman,Steven M. Pitzenberger,Ruth F. Nutt,Stephen F. Brady,C. D. COLTON,Daniel F. Veber	1993	14
14	3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 9. The synthesis and biological evaluation of novel simvastatin analogs Journal of Medicinal Chemistry ·George D. Hartman,Wasyl Halczenko,Mark E. Duggan,Jill S. Imagire,Robert L. Smith,Steven M. Pitzenberger,Susan L. Fitzpatrick,Alfred W. Alberts,R. Bostedor	1992	8
15	NMR and molecular modeling characterization of RGD containing peptides International journal of peptide & protein research ·Michael J. Bogusky,Adel M. Naylor,Steven M. Pitzenberger,R. F. NUTT,S.F. Brady,C. D. COLTON,John T. Sisko,Paul Anderson,Daniel F. Veber	1992	48
16	HIV-1 protease inhibitory activity of L-694,746, a novel metabolite of L-689,502 Biochemical and Biophysical Research Communications ·Russell B. Lingham,Byron H. Arison,Lawerence F. Colwell,Amy Hsu,Georgette Dezeny,Wayne J. Thompson,George M Garrity,MAGDA M. GAGLIARDI,Frederick W. Hartner,Paul L. Darke,Suresh K. Balani,Steven M. Pitzenberger,Joan S. Murphy,Harri G. Ramjit,Edward Inamine,L. Treiber	1991	5
17	Proton NMR assignments and secondary structure of the snake venom protein echistatin Biochemistry ·Yuan Chen,Steven M. Pitzenberger,Victor M. Garsky,Patricia K. Lumma,Gautam Sanyal,Jean Baum	1991	43
18	Regioselectivity and stereoselectivity in the metabolism of HMG-CoA reductase inhibitors Biochemical and Biophysical Research Communications ·Kamlesh P. Vyas,Prasad H. Kari,Steven M. Pitzenberger	1990	9
19	In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase. Drug Metabolism and Disposition ·S. Vickers,C A Duncan,Kamlesh P. Vyas,P H Kari,Byron H. Arison,Shimoga R. Prakash,Harri G. Ramjit,Steven M. Pitzenberger,G. E. STOKKER,D E Duggan	1990	136
20	Metabolism of simvastatin s by rat and mouse liver microsomes The FASEB Journal ·Kamlesh P. Vyas,P H Kari,S. Vickers,C. Duncan,Steven M. Pitzenberger,B A Arison,Harri G. Ramjit,D E Duggan	1988	1

About Steven M. Pitzenberger

Steven M. Pitzenberger is a scholar working on Virology, Organic Chemistry and Pharmaceutical Science, having authored 49 papers that have together received 1.5k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (5 papers), Synthesis and Biological Evaluation (5 papers), Chemical Synthesis and Analysis (5 papers), Protein Structure and Dynamics (4 papers), Cancer, Lipids, and Metabolism (4 papers), Analytical Chemistry and Chromatography (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Lipoproteins and Cardiovascular Health (3 papers). The work is most often cited by research in Immunology and Allergy (104 citations), Pharmacology (135 citations) and Organic Chemistry (418 citations). Steven M. Pitzenberger has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Keith M. Witherup, Paul Anderson, Harri G. Ramjit, Sándor Varga, Michael J. Salvatore, Amy C. Graham, William C. Lumma, Richard W. Ransom, Gideon A. Rodan and Azriel Schmidt. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact